Mumbai: Shreya Life Sciences Pvt. Ltd on Thursday said it has launched the world’s first insulin spray for patients with diabetes.
The insulin spray, to be sold under the brand name of Oral Recosulin, is based on technology developed by the company’s US collaborator Generex Biotechnology Inc.
The new technology delivers insulin through directly to the vascular system, and could serve as an alternative treatment for diabetics who have an acute injection phobia.
Currently, injections are the most common form of administering insulin doses for people with diabetes.